About

Matthew H. Kulke, MD is Chief of Hematology/Oncology at Boston Medical Center and Co-Director of the BU/BMC Cancer Center. He is also the Zoltan Kohn Professor at Boston University Chobanian & Avedisian School of Medicine (Boston University Chobanian & Avedisian School of Medicine). Dr. Kulke is internationally recognized for his expertise in neuroendocrine tumors and has led numerous national and international clinical trials resulting in new drugs and therapies for neuroendocrine tumors. Dr. Kulke has published more than 200 peer-reviewed publications on preclinical and clinical research in this area. He is a member of the Shipley Prostate Cancer Research Center at Boston University Chobanian & Avedisian School of Medicine and also the Evans Center for Interdisciplinary Biomedical Research at Boston University.

  • Administrative Title

    Zoltan Kohn Professor of Medicine, Boston University Chobanian and Avedisian School of Medicine. Member, Evans Center for Interdisciplinary Biomedical Research, Boston University. Member, Shipley Prostate Cancer Research Center at Boston University Chobanian and Avedisian School of Medicine.

  • Residency

    Internal Medicine, Brigham and Women’s Hospital
  • Fellowship

    Medical Oncology, Dana-Farber Cancer Institute
  • Education

    University of California San Francisco School of Medicine, 1992
  • Board Certifications

    Medical Oncology, American Board of Internal Medicine

Affiliations

Affiliations